1795.TW
Lotus Pharmaceutical Co., Ltd.
TaiwanTWDEQUITY
Healthcare
DELAYED
Neutral
-16/100
Last price
182.00
▲ 6.00 (3.41%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
176.50
Prev close
176.00
Day high
182.50
Day low
176.50
Volume
1.41M
Market cap
$48.55B
P/E (TTM)
12.83
52W range
168.31 – 364.76
Day trading desk
Gap from prior close
+0.28%
Prior close 176.00
VWAP
180.64
+0.75% from price
Relative volume
1.02×
Normal
Session range
3.40%
176.50 – 182.50
Position in range
92%
Near session high
ATR (14D)
3.04
1.67% of price
Prior day high
178.50
PDH
Prior day low
176.00
PDL
Bid / ask spread
—
Quote not published
Session volume
1.36M
Avg 1.32M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+1.96%
+0.0%
1M
+0.27%
-0.9%
3M
-11.75%
-16.3%
6M
-14.61%
-32.8%
YTD
-34.67%
-48.9%
1Y
-2.70%
-19.1%
3Y
-25.45%
-107.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 1795.TW open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
129.62M
Total on file
Fundamentals
Market cap$48.55B
Enterprise value$99.59B
Revenue (TTM)$28.49B
Gross profit$15.31B
EBITDA$9.20B
Net income$3.77B
EPS (TTM)$14.22
Free cash flow$-59.90M
Total cash$6.33B
Total debt$58.45B
Book value / share$90.12
Shares outstanding266.04M
Float137.49M
Short % of float—
Dividend yield1.46%
Beta (5Y)0.66
Valuation & profitability ratios
Trailing P/E12.83
Forward P/E7.67
PEG ratio—
Price / sales—
Price / book2.02
EV / revenue3.50
EV / EBITDA10.82
Gross margin53.75%
Operating margin26.49%
Profit margin13.22%
Return on equity16.86%
Return on assets6.20%
Debt / equity240.47
Current ratio1.46
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $20.51B | $18.58B | $16.96B | $14.63B | +10.4% |
| Operating revenue | $20.51B | $18.58B | $16.96B | $14.63B | +10.4% |
| Cost of revenue | $8.60B | $7.66B | $7.57B | $6.83B | +12.3% |
| Gross profit | $11.91B | $10.92B | $9.38B | $7.81B | +9.0% |
| Research & development | $986.71M | $773.89M | $720.83M | $520.45M | +27.5% |
| Selling, general & admin | $5.02B | $4.13B | $3.76B | $3.18B | +21.5% |
| Total operating expense | $6.01B | $4.91B | $4.48B | $3.70B | +22.5% |
| Operating income | $5.90B | $6.02B | $4.90B | $4.11B | -2.0% |
| Net interest income | -$779.98M | -$469.33M | -$525.85M | -$378.95M | -66.2% |
| Pre-tax income | $5.72B | $6.36B | $5.10B | $3.94B | -10.1% |
| Tax provision | $998.12M | $1.29B | $997.30M | $919.46M | -22.9% |
| Net income | $4.72B | $5.07B | $4.11B | $3.02B | -6.8% |
| Net income to common | $4.72B | $5.07B | $4.11B | $3.02B | -6.8% |
| Basic EPS | 18.14 | 19.35 | 15.72 | 11.59 | -6.3% |
| Diluted EPS | 18.04 | 19.23 | 15.67 | 11.54 | -6.2% |
| EBIT | $6.61B | $6.93B | $5.66B | $4.32B | -4.6% |
| EBITDA | $8.15B | $8.21B | $6.87B | $5.26B | -0.8% |
| Basic shares | 260.26M | 261.85M | 261.24M | 260.63M | -0.6% |
| Diluted shares | 261.64M | 263.40M | 262.02M | 261.76M | -0.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $7.74B | $6.03B | $1.77B | $1.98B | +28.3% |
| Cash & short-term investments | $7.74B | $6.03B | $1.77B | $1.98B | +28.3% |
| Accounts receivable | $6.68B | $7.21B | $6.26B | $4.39B | -7.4% |
| Inventory | $9.65B | $3.83B | $3.78B | $3.33B | +151.7% |
| Total current assets | $26.45B | $18.10B | $12.65B | $10.66B | +46.2% |
| Property, plant & equipment | $7.61B | $3.67B | $3.51B | $3.15B | +107.5% |
| Goodwill & intangibles | $57.28B | $13.96B | $13.03B | $12.98B | +310.2% |
| Total assets | $106.15B | $40.10B | $32.99B | $29.53B | +164.7% |
| Total current liabilities | $16.88B | $8.44B | $4.52B | $5.89B | +100.0% |
| Current debt | $4.15B | $5.00B | $1.81B | $215.87M | -17.1% |
| Long-term debt | $42.45B | $8.38B | $9.52B | $8.60B | +406.3% |
| Total debt | $47.48B | $13.67B | $11.58B | $8.92B | +247.4% |
| Total liabilities | $82.37B | $18.92B | $15.66B | $15.66B | +335.4% |
| Retained earnings | $15.90B | $12.66B | $8.90B | $4.82B | +25.6% |
| Shareholder equity | $23.78B | $21.18B | $17.33B | $13.87B | +12.3% |
| Working capital | $9.57B | $9.66B | $8.13B | $4.77B | -0.9% |
| Net tangible assets | -$33.50B | $7.22B | $4.30B | $884.91M | -564.2% |
| Shares issued | 266.87M | 265.81M | 264.96M | 262.59M | +0.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $5.72B | $6.36B | $5.10B | $3.94B | — | -10.1% |
| Depreciation & amortisation | $1.54B | $1.28B | $1.21B | $936.87M | — | +19.7% |
| Stock-based compensation | $279.38M | $348.65M | $106.49M | $39.41M | — | -19.9% |
| Change in working capital | $1.76B | -$711.95M | -$3.44B | -$909.70M | — | +346.9% |
| Operating cash flow | $7.48B | $6.15B | $1.61B | $3.72B | — | +21.6% |
| Capital expenditure | -$4.35B | -$1.47B | -$3.28B | -$3.07B | — | -197.2% |
| Investing cash flow | -$12.47B | -$2.69B | -$3.25B | -$4.66B | — | -363.4% |
| Share buybacks | -$780.99M | $0 | — | $0 | -$57.35M | — |
| Dividends paid | -$1.52B | -$1.23B | -$906.23M | -$506.06M | — | -23.4% |
| Financing cash flow | $6.90B | $714.09M | $1.40B | $1.26B | — | +865.7% |
| Free cash flow | $3.13B | $4.69B | -$1.66B | $650.03M | — | -33.3% |
| End cash position | $7.74B | $6.03B | $1.77B | $1.98B | — | +28.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $8.81B | $8.64B | $6.26B | $4.77B | $4.75B | — | +1.9% |
| Operating revenue | $8.81B | $8.64B | $6.26B | $4.77B | $4.75B | — | +1.9% |
| Cost of revenue | $4.08B | $4.26B | $2.80B | $2.04B | $1.95B | — | -4.2% |
| Gross profit | $4.73B | $4.39B | $3.46B | $2.73B | $2.79B | — | +7.8% |
| Research & development | $246.02M | $279.59M | $229.15M | $447.99M | $164.47M | — | -12.0% |
| Selling, general & admin | $2.15B | $2.14B | $1.74B | $1.10B | $1.13B | — | +0.1% |
| Total operating expense | $2.39B | $2.42B | $1.97B | $1.55B | $1.29B | — | -1.3% |
| Operating income | $2.34B | $1.96B | $1.49B | $1.19B | $1.50B | — | +19.0% |
| Net interest income | -$1.19B | -$1.18B | -$462.11M | -$99.17M | -$101.18M | — | -0.4% |
| Pre-tax income | $990.25M | $725.90M | $1.32B | $1.83B | $827.29M | — | +36.4% |
| Tax provision | $348.00M | $158.70M | $194.58M | $397.56M | $99.03M | — | +119.3% |
| Net income | $642.25M | $567.20M | $1.12B | $1.43B | $728.26M | — | +13.2% |
| Net income to common | $642.25M | $567.20M | $1.12B | $1.43B | $728.26M | — | +13.2% |
| Basic EPS | 2.47 | 2.18 | — | 5.53 | 2.78 | 5.47 | +13.3% |
| Diluted EPS | 2.46 | 2.17 | — | 5.51 | 2.78 | 5.44 | +13.4% |
| EBIT | $2.20B | $1.94B | $1.81B | $1.96B | $960.36M | — | +13.6% |
| EBITDA | $2.84B | $2.57B | $2.26B | $2.33B | $1.33B | — | +10.5% |
| Basic shares | 260.02M | 259.90M | — | 259.44M | 261.75M | 262.45M | +0.0% |
| Diluted shares | 261.08M | 261.75M | — | 260.38M | 261.75M | 264.45M | -0.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $6.33B | $6.20B | $7.74B | $5.67B | $4.11B | +2.1% |
| Cash & short-term investments | $6.33B | $6.20B | $7.74B | $5.67B | $4.11B | +2.1% |
| Accounts receivable | $8.54B | $8.19B | $6.68B | $5.53B | $6.29B | +4.3% |
| Inventory | $8.90B | $9.25B | $9.65B | $3.93B | $3.89B | -3.8% |
| Total current assets | $25.66B | $25.90B | $26.45B | $16.08B | $15.11B | -0.9% |
| Property, plant & equipment | $7.57B | $7.68B | $7.61B | $3.52B | $3.55B | -1.4% |
| Goodwill & intangibles | $58.81B | $58.73B | $57.28B | $15.34B | $15.50B | +0.1% |
| Total assets | $108.59B | $107.53B | $106.15B | $39.60B | $38.16B | +1.0% |
| Total current liabilities | $17.52B | $16.24B | $16.88B | $8.87B | $9.77B | +7.9% |
| Current debt | $5.66B | $3.35B | $4.15B | $5.75B | $5.44B | +69.1% |
| Long-term debt | $43.26B | $43.71B | $42.45B | $6.44B | $5.95B | -1.0% |
| Total debt | $49.80B | $47.98B | $47.48B | $12.42B | $11.62B | +3.8% |
| Total liabilities | $84.28B | $83.50B | $82.37B | $17.43B | $17.80B | +0.9% |
| Retained earnings | $16.41B | $15.80B | $15.90B | $14.74B | $13.30B | +3.8% |
| Shareholder equity | $24.31B | $24.03B | $23.78B | $22.17B | $20.36B | +1.1% |
| Working capital | $8.14B | $9.66B | $9.57B | $7.21B | $5.34B | -15.7% |
| Net tangible assets | -$34.50B | -$34.69B | -$33.50B | $6.83B | $4.87B | +0.6% |
| Shares issued | 266.87M | 266.87M | 266.87M | 265.81M | 261.75M | 0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $990.25M | $725.90M | $1.32B | $1.83B | $827.29M | +36.4% |
| Depreciation & amortisation | $637.11M | $631.58M | $450.37M | $366.30M | $367.43M | +0.9% |
| Stock-based compensation | $52.01M | $62.82M | $64.10M | $73.27M | $69.92M | -17.2% |
| Change in working capital | -$572.27M | -$1.89B | $305.24M | $1.25B | -$423.96M | +69.8% |
| Operating cash flow | $701.37M | -$24.95M | $1.35B | $2.47B | $931.41M | +2,910.5% |
| Capital expenditure | -$1.07B | -$1.23B | -$1.60B | -$262.10M | -$616.94M | +13.4% |
| Investing cash flow | -$2.39B | -$1.24B | -$9.73B | -$263.37M | -$624.00M | -92.7% |
| Share buybacks | — | — | $0 | $0 | — | — |
| Dividends paid | — | — | $0 | — | — | — |
| Financing cash flow | $1.84B | -$347.08M | $10.42B | -$793.82M | -$1.41B | +631.2% |
| Free cash flow | -$367.58M | -$1.26B | -$255.44M | $2.21B | $314.47M | +70.8% |
| End cash position | $6.33B | $6.20B | $7.74B | $5.67B | $4.11B | +2.1% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 2.30 | 2.43 | +5.6% |
| Mar 2026 | 2.71 | 1.97 | -27.3% |
| Dec 2025 | 5.76 | 4.26 | -25.9% |
| Sep 2025 | 4.44 | 5.46 | +23.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 4.04 | 3 | $8.98B | +88.3% |
| Next quarter | 4.28 | 3 | $9.36B | +49.5% |
| Current year | 13.15 | 2 | $35.82B | +74.6% |
| Next year | 23.79 | 4 | $41.12B | +14.8% |
Analyst targets & ownership
Mean target$292.32
High target$493.58
Low target$197.43
Implied upside60.61%
Analyst count5
ConsensusNONE
Strong buy / Buy3 / 1
Hold2
Sell / Strong sell0 / 0
Held by insiders48.06%
Held by institutions7.94%
Institutions holding33
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
177.50
+2.54% from price
SMA 20
177.65
+2.73% from price
SMA 50
181.86
+0.35% from price
SMA 100
187.08
-2.71% from price
SMA 200
224.48
-18.70% from price
EMA 12
178.22
+2.12% from price
EMA 26
179.59
+1.34% from price
EMA 50
182.75
-0.41% from price
RSI (14)
55.0
Neutral
MACD (12,26,9)
-1.36
Hist 0.59
ATR (14)
3.04
1.66% of price
Realised vol 30D
20.2%
Annualised
Bollinger upper
181.99
20, 2σ
Bollinger lower
173.31
20, 2σ
50 / 200 cross
Death
181.86 vs 224.48
Trend bias
Below 200
-18.70%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.10
Less volatile than market
Correlation to SPY
-0.03
Largely independent
Realised vol 30D
20.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-52.3%
Peak to trough
Max drawdown 5Y
-52.3%
Peak to trough
ATR 14
3.04
1.66% of price
Beta (reported)
0.66
5Y monthly, from filing
Dividends & splits
Forward rate$2.57 / yr
Forward yield1.46%
5-year avg yield0.87%
Payout ratio40.13%
Ex-dividend dateAug 31, 2026
Next pay date—
Last split1013.0067:1000
Split dateAug 31, 2026
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.